294 related articles for article (PubMed ID: 32863062)
1. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease.
Hirai K; Tanaka A; Homma T; Goto Y; Akimoto K; Uno T; Yoshitaka U; Miyata Y; Inoue H; Ohta S; Suzuki S; Sagara H
Clin Nutr; 2021 Mar; 40(3):1274-1280. PubMed ID: 32863062
[TBL] [Abstract][Full Text] [Related]
2. Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.
Sun J; Yang H; Cai W; Zheng J; Shen N; Yang X; Pan B; Zhang W; Chen X; Shen X
BMC Gastroenterol; 2022 Jan; 22(1):26. PubMed ID: 35045814
[TBL] [Abstract][Full Text] [Related]
3. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis.
Fujita K; Ohkubo H; Nakano A; Takeda N; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
BMC Pulm Med; 2022 May; 22(1):203. PubMed ID: 35606777
[TBL] [Abstract][Full Text] [Related]
4. The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients.
Amado CA; García-Unzueta MT; Lavin BA; Guerra AR; Agüero J; Ramos L; Muñoz P
Respiration; 2019; 97(4):302-309. PubMed ID: 30481791
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the serum creatinine/cystatin C ratio in patients with chronic obstructive pulmonary disease.
Kawasaki Y; Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
Respir Investig; 2024 Jan; 62(1):143-149. PubMed ID: 38134662
[TBL] [Abstract][Full Text] [Related]
6. Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Huang D; Xie C; Sun C; Chen M; Li L; Yi H; Liao J; Zhao X; Shen X; He D; Li D; Wu D
Int J Chron Obstruct Pulmon Dis; 2022; 17():781-789. PubMed ID: 35422619
[TBL] [Abstract][Full Text] [Related]
7. Serum Creatinine/Cystatin C Ratio Associated with Cross-Sectional Area of Erector Spinae Muscles and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease.
Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
Int J Chron Obstruct Pulmon Dis; 2021; 16():3513-3524. PubMed ID: 34992359
[TBL] [Abstract][Full Text] [Related]
8. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease.
Lin YL; Chen SY; Lai YH; Wang CH; Kuo CH; Liou HH; Hsu BG
Clin Nutr; 2020 Aug; 39(8):2435-2441. PubMed ID: 31732290
[TBL] [Abstract][Full Text] [Related]
9. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease.
Lu YW; Tsai YL; Chou RH; Kuo CS; Chang CC; Huang PH; Lin SJ
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1509-1515. PubMed ID: 33810966
[TBL] [Abstract][Full Text] [Related]
10. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.
Ding P; Guo H; Sun C; Chen S; Yang P; Tian Y; Lowe S; Zhao Q
Front Nutr; 2022; 9():963265. PubMed ID: 36118766
[TBL] [Abstract][Full Text] [Related]
11. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
[TBL] [Abstract][Full Text] [Related]
12. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis.
Lin T; Jiang T; Huang X; Xu P; Liang R; Song Q; Tu X; Zhao Y; Huang L; Yue J; Wu C
Age Ageing; 2024 Jan; 53(1):. PubMed ID: 38251741
[TBL] [Abstract][Full Text] [Related]
14. Serum creatinine/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults.
Tan L; Li R; Hu X; Zhu Y; Bao T; Zuo Y; Yang M
Sci Rep; 2020 Aug; 10(1):14028. PubMed ID: 32820230
[TBL] [Abstract][Full Text] [Related]
15. Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels.
Kim DJ; Kang HS; Choi HS; Cho HJ; Kim ES; Keum B; An H; Kim JH; Seo YS; Kim YS; Yim HJ; Jeen YT; Lee HS; Um SH; Kim CD; Ryu HS
Korean J Hepatol; 2011 Jun; 17(2):130-8. PubMed ID: 21757984
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of serum creatinine/cystatin C in neurocritically ill patients.
Wang S; Xie L; Xu J; Hu Y; Wu Y; Lin Z; Pan S
Brain Behav; 2019 Dec; 9(12):e01462. PubMed ID: 31701661
[TBL] [Abstract][Full Text] [Related]
17. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List.
Mauro E; Crespo G; Martinez-Garmendia A; Gutierrez-Acevedo MN; Diaz JM; Saidman J; Bermudez C; Ortiz-Patron J; Garcia-Olveira L; Zalazar F; Narvaez A; Spina JC; Orta R; Savluk L; Piano S; Marciano S; Gadano A
Transplantation; 2020 Jul; 104(7):e188-e198. PubMed ID: 32150034
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
Zhao X; Su R; Hu R; Chen Y; Xu X; Yuan Y; Zhang J; Zhang W; Yang Y; Chen M; Li D; Wu B; Huang D; Wu D
BMC Geriatr; 2023 Feb; 23(1):89. PubMed ID: 36774462
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C as a Predictor of In-Hospital Mortality After Exacerbation of COPD.
Hu G; Wu Y; Zhou Y; Yu Y; Liang W; Ran P
Respir Care; 2016 Jul; 61(7):950-7. PubMed ID: 27072013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]